Cohance Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 3,499.94 Cr
as on 14-12-2024
- Paid Up Capital ₹ 3,394.66 Cr
as on 14-12-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 581.47 Cr
as on 14-12-2024
- Satisfied Charges ₹ 281.77 Cr
as on 14-12-2024
- Revenue 8127.37%
(FY 2022)
- Profit 18793.93%
(FY 2022)
- Ebitda 5681300.00%
(FY 2022)
- Net Worth 2.73%
(FY 2022)
- Total Assets 78.00%
(FY 2022)
About Cohance Lifesciences
The Corporate was formerly known as Ai Pharmed Consultancy India Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3,499.94 Cr and a paid-up capital of Rs 3,394.66 Cr.
The company currently has active open charges totaling ₹581.47 Cr. The company has closed loans amounting to ₹281.77 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Cohance Lifesciences Limited India are Sudarsan Maddi as CFO and Praneeth Gunda as Company Secretary. Shweta Jalan, Anil Chanana, Bhaskar Iyer, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24100MH2020PLC402958
- Company No.
141437
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
06 Jul 2020
- Date of AGM
12 Jul 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Cohance Lifesciences?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkatanaga Raju  | Managing Director | 27-Oct-2022 | Current |
| Sudarsan Maddi | CFO | 22-Aug-2024 | Current |
| Praneeth Gunda | Company Secretary | 01-Nov-2022 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pankaj Patwari | Director | 20-Jul-2020 | Current |
| Anil Chanana | Director | 27-Oct-2022 | Current |
| Shweta Jalan | Director | 12-Jul-2021 | Current |
| Bhaskar Iyer | Director | 27-Oct-2022 | Current |
| Abhijit Mukherjee | Director | 27-Oct-2022 | Current |
Financial Performance of Cohance Lifesciences.
Cohance Lifesciences Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 8127.37% increase. The company also saw a substantial improvement in profitability, with a 18793.93% increase in profit. The company's net worth moved up by a moderate rise of 2.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cohance Lifesciences?
In 2023, Cohance Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Oct 2023 | ₹50.00 Cr | Open |
Citi Bank N.A. Creation Date: 17 Aug 2023 | ₹40.00 Cr | Open |
Axis Bank Limited Creation Date: 20 May 2023 | ₹50.00 Cr | Open |
How Many Employees Work at Cohance Lifesciences?
Cohance Lifesciences has a workforce of 27 employees as of Jul 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cohance Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cohance Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
